• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创伤性损伤后脊髓中强啡肽免疫反应性增加。

Increased dynorphin immunoreactivity in spinal cord after traumatic injury.

作者信息

Faden A I, Molineaux C J, Rosenberger J G, Jacobs T P, Cox B M

出版信息

Regul Pept. 1985 May;11(1):35-41. doi: 10.1016/0167-0115(85)90029-1.

DOI:10.1016/0167-0115(85)90029-1
PMID:2861626
Abstract

Opiate antagonists, at high doses, have been shown to improve physiological variables and outcome after experimental spinal injury. Dynorphin appears to be unique amongst opioids in producing hindlimb paralysis after intrathecal injection. Taken together, these findings suggest a possible pathophysiological role for endogenous opioids, particularly dynorphin, in spinal injury. In the present studies we examined the relationship between changes in dynorphin immunoreactivity (Dyn-ir) in rat spinal cord after traumatic injury and the subsequent motor dysfunction. Trauma was associated with significantly increased Dyn-ir at the injury site, but not distant from the lesion. Dyn-ir was found elevated as early as 2 h and as late as 2 weeks after trauma, and was significantly correlated with the degree of injury. These data are consistent with the hypothesis that dynorphin systems may be involved in the secondary injury that follows spinal trauma.

摘要

阿片类拮抗剂在高剂量时已被证明可改善实验性脊髓损伤后的生理变量和预后。强啡肽在鞘内注射后能导致后肢麻痹,这在阿片类药物中似乎是独特的。综合来看,这些发现表明内源性阿片类物质,尤其是强啡肽,在脊髓损伤中可能具有病理生理作用。在本研究中,我们检测了创伤性损伤后大鼠脊髓中强啡肽免疫反应性(Dyn-ir)的变化与随后运动功能障碍之间的关系。创伤与损伤部位的Dyn-ir显著增加有关,但远离损伤部位则无此现象。创伤后最早在2小时以及最晚在2周时发现Dyn-ir升高,且与损伤程度显著相关。这些数据与强啡肽系统可能参与脊髓创伤后继发性损伤的假说一致。

相似文献

1
Increased dynorphin immunoreactivity in spinal cord after traumatic injury.创伤性损伤后脊髓中强啡肽免疫反应性增加。
Regul Pept. 1985 May;11(1):35-41. doi: 10.1016/0167-0115(85)90029-1.
2
Endogenous opioids in spinal cord injury: a critical evaluation.脊髓损伤中的内源性阿片类物质:一项批判性评估。
Cent Nerv Syst Trauma. 1986 Fall;3(4):295-315. doi: 10.1089/cns.1986.3.295.
3
Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury.创伤性损伤后大鼠脊髓中的内源性阿片免疫反应性
Ann Neurol. 1985 Apr;17(4):386-90. doi: 10.1002/ana.410170414.
4
Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.阿片类和非阿片类机制可能在脊髓损伤中对强啡肽的病理生理作用有所贡献。
Ann Neurol. 1990 Jan;27(1):67-74. doi: 10.1002/ana.410270111.
5
Neuropeptides in spinal cord injury: comparative experimental models.脊髓损伤中的神经肽:比较实验模型
Peptides. 1983 Sep-Oct;4(5):631-4. doi: 10.1016/0196-9781(83)90009-8.
6
Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism.强啡肽A-(1-17)通过阿片受体介导的机制诱导游离脂肪酸、兴奋性氨基酸和运动功能发生改变。
J Neurosci. 1990 Dec;10(12):3793-800. doi: 10.1523/JNEUROSCI.10-12-03793.1990.
7
Effects of traumatic injury on dynorphin immunoreactivity in spinal cord.创伤性损伤对脊髓中强啡肽免疫反应性的影响。
Neuropeptides. 1985 Feb;5(4-6):571-4. doi: 10.1016/0143-4179(85)90082-4.
8
Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.强啡肽相关肽通过非阿片类作用导致大鼠运动功能障碍。
Br J Pharmacol. 1984 Feb;81(2):271-6. doi: 10.1111/j.1476-5381.1984.tb10074.x.
9
N-methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies.
Brain Res. 1992 May 15;580(1-2):255-64. doi: 10.1016/0006-8993(92)90952-6.
10
Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.强啡肽A诱导的大鼠后肢麻痹和脊髓损伤不会因κ阿片受体拮抗剂去甲二氢吗啡酮而改变。
Brain Res. 1989 Sep 11;497(1):155-62. doi: 10.1016/0006-8993(89)90982-7.

引用本文的文献

1
Morphine-induced changes in the function of microglia and macrophages after acute spinal cord injury.吗啡诱导急性脊髓损伤后小胶质细胞和巨噬细胞功能的改变。
BMC Neurosci. 2022 Oct 10;23(1):58. doi: 10.1186/s12868-022-00739-3.
2
Adverse Effects of Repeated, Intravenous Morphine on Recovery after Spinal Cord Injury in Young, Male Rats Are Blocked by a Kappa Opioid Receptor Antagonist.反复静脉注射吗啡对年轻雄性大鼠脊髓损伤后恢复的不良影响可被κ阿片受体拮抗剂阻断。
J Neurotrauma. 2022 Dec;39(23-24):1741-1755. doi: 10.1089/neu.2022.0208. Epub 2022 Oct 5.
3
Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury.
去甲二氢吗啡酮可阻断脊髓损伤后吗啡的不良反应。
J Neurotrauma. 2017 Mar 15;34(6):1164-1174. doi: 10.1089/neu.2016.4601. Epub 2016 Nov 4.
4
Dynorphin A analogs for the treatment of chronic neuropathic pain.用于治疗慢性神经性疼痛的强啡肽A类似物。
Future Med Chem. 2016;8(2):165-77. doi: 10.4155/fmc.15.164. Epub 2016 Jan 29.
5
Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord.强啡肽A片段的阿片样和非阿片样作用中的神经病理性可塑性及其与大鼠脊髓神经元活动中缓激肽B2受体的相互作用。
Neuropharmacology. 2014 Oct;85:375-83. doi: 10.1016/j.neuropharm.2014.06.005. Epub 2014 Jun 14.
6
Perivascular expression and potent vasoconstrictor effect of dynorphin A in cerebral arteries.在脑血管中,强啡肽 A 的血管周表达和强效血管收缩作用。
PLoS One. 2012;7(5):e37798. doi: 10.1371/journal.pone.0037798. Epub 2012 May 25.
7
Estradiol treatment prevents injury induced enhancement in spinal cord dynorphin expression.雌二醇治疗可预防损伤诱导的脊髓强啡肽表达增强。
Front Physiol. 2012 Feb 22;3:28. doi: 10.3389/fphys.2012.00028. eCollection 2012.
8
Spinal dynorphin and bradykinin receptors maintain inflammatory hyperalgesia.脊髓强啡肽和缓激肽受体维持炎性痛觉过敏。
J Pain. 2008 Dec;9(12):1096-105. doi: 10.1016/j.jpain.2008.06.005. Epub 2008 Oct 31.
9
Pronociceptive actions of dynorphin via bradykinin receptors.强啡肽通过缓激肽受体产生的促伤害感受作用。
Neurosci Lett. 2008 Jun 6;437(3):175-9. doi: 10.1016/j.neulet.2008.03.088. Epub 2008 Apr 8.
10
Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation.实验性神经病变中增强的诱发兴奋性递质释放需要下行易化作用。
J Neurosci. 2003 Sep 10;23(23):8370-9. doi: 10.1523/JNEUROSCI.23-23-08370.2003.